En prevención primaria, bajas dosis de aspirina no disminuirían el riesgo de eventos cardiovasculares en pacientes con diabetes tipo 2 / In primary prevention, low doses of aspirin would not decrease the risk of cardiovascular events in patients with type 2 diabetes
Evid. actual. práct. ambul
;
21(2): 46-47, jul. 2018. tab.
Article
in Spanish
| LILACS
| ID: biblio-1016526
Subject(s)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Cardiovascular Diseases
/
Aspirin
/
Diabetes Complications
Type of study:
Controlled clinical trial
/
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Evid. actual. práct. ambul
Journal subject:
Medicine
/
Delivery of Health Care
Year:
2018
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital Italiano de Buenos Aires/AR
Similar
MEDLINE
...
LILACS
LIS